Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Harmonicare Medical Holdings is a prominent private healthcare group in China primarily focused on maternity and pediatric services. As one of the largest private providers in the sector, the company operates a network of specialty hospitals across major urban centers, including Beijing, Shenzhen, and Guangzhou, under brands such as "HarMoniCare" and "Modern." Its comprehensive service portfolio covers the entire life cycle of women and children, encompassing prenatal care, delivery services, postpartum recovery, and specialized pediatric treatments. Although previously listed on the Hong Kong Stock Exchange, the company was delisted in 2021 following a period of restructuring and internal management changes. Harmonicare continues to serve the premium healthcare market in China, emphasizing high-quality clinical care and personalized patient experiences.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Harmonicare Medical Holdings.